COLLPLANT ANNOUNCES A $3.7 MILLION PRIVATE PLACEMENTPRNewsWire · Oct 9, 2026
LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering SimulationsPRNewsWire · Oct 6, 2026
Critical Contrast: CollPlant Biotechnologies (NASDAQ:CLGN) & CareDx (NASDAQ:CDNA)Defense World · Oct 5, 2026
COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATEPRNewsWire · Sep 30, 2026
CollPlant Biotechnologies Ltd. Sponsored ADR (NASDAQ:CLGN) Stock Short Interest Declines 60.2%Defense World · Sep 30, 2026
LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC WorkloadsPRNewsWire · Sep 24, 2026CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine enterprise operating across the United States, Canada, and Europe. The company primarily engages in the three-dimensional (3D) bioprinting of tissues and organs, alongside developing solutions for medical aesthetics. All of CollPlant's offerings are underpinned by its proprietary plant-based genetic engineering technology, which facilitates the production of recombinant type I human collagen.
| Date | Est. | Actual | |
|---|---|---|---|
| Sep 30, 2026 | -$2.45 | -$1.89 | Beat |
| May 29, 2026 | -$0.24 | -$0.23 | Beat |
| Mar 26, 2026 | -$2.98 | -$0.67 | Beat |
| Nov 26, 2025 | $1.55 | -$2.70 | Miss |
| Aug 20, 2025 | -$1.00 | -$2.80 | Miss |
| May 28, 2025 | -$3.70 | -$0.13 | Beat |